Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin

Eleonora Russo, Giuseppe Penno, Stefano Del Prato Department of Clinical and Experimental Medicine, Section of Diabetes and Metabolic Disease, Azienda Ospedaliero Universitaria di Pisa, and University of Pisa, Pisa, Italy Background: Dipeptidyl peptidase-4 (DPP-4) inhibitors are novel classified ora...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Russo E, Penno G, Del Prato S
Format: article
Langue:EN
Publié: Dove Medical Press 2013
Sujets:
Accès en ligne:https://doaj.org/article/48d2c4b76bb942349b9033e8f089a3d7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires